Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Chikage Iguchi"'
Autor:
Keiko Inakami, Noriko Fujita, Chikage Iguchi, Yukie Enomoto, Junya Minohata, Atsushi Sata, Yoshimasa Miyagawa, Tetsu Yanagisawa, Tomokazu Saitoh, Takashi Nomura, Yuka Sawai, Keiko Takahara, Tsutomu Kasugai, Eiichi Shiba
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background Pembrolizumab (PEM), an immune checkpoint inhibitor (ICI), is often used for triple-negative breast cancer, but can also be used to treat solid tumors that exhibit high microsatellite instability (MSI-High). However, patients with
Externí odkaz:
https://doaj.org/article/20aff28844e8466f92c48eee2fbc960b
Autor:
Noriko Fujita, Koichi Fujita, Seung Jin Kim, Chikage Iguchi, Takashi Nomura, Toyokazu Aono, Tetsu Yanagisawa, Yukie Enomoto, Keiko Inakami, Yoshimasa Miyagawa, Riki Tomoike, Tsutomu Kasugai, Eiichi Shiba
Publikováno v:
Oncology. 100(5)
Background: De-escalation therapy omitting anthracycline has been generally adopted for patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer in the adjuvant setting, but not in the neoadjuvant chemotherapy (NAC)
Autor:
Chikage Iguchi, Eiichi Shiba, Noriko Fujita, Keiko Inakami, Hitoshi Yamamoto, Tsutomu Kasugai, Takashi Nomura, Tetsu Yanagisawa, Yukie Enomoto, Toyokazu Aono
Publikováno v:
Oncology. 98:35-41
Background: It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive
Publikováno v:
ONCOLOGY LETTERS. 2(2):223-228
Phyllodes tumor (PT) is a rare type of breast tumor that rarely occurs with breast carcinoma. This study evaluated a 53-year-old female patient with a benign PT with ductal carcinoma in situ (DCIS) within the tumor. A firm, painless, well-demarcated
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72:2302-2306
虫垂結石症は,結石が指圧でつぶれない,腹部単純X線に写る程度の無機物を含むもの,等の定義があるが,まだ議論があり結石の成分分析等の詳細な検討は少ない.症例1:21歳,男性.
Autor:
Ming Dong, Michio Takamura, Susumu Sasaki, Chikage Iguchi, Masayuki Itakura, Katsuhiro Tamura, Kunihiro Yamasawa, Yoshinori Nio, Tomoko Toga
Publikováno v:
Pancreas. 22:230-239
Summary: The Bcl-2 family of genes plays important roles in the regulation of apoptosis. The present study was designed to assess the clinicopathologic significance of apoptosis and the expression of the apoptosis-inhibitory Bcl-2 protein (pBcl-2) an
Autor:
Yoshinori Nio, Yoshimitu Minari, Noriyuki Hirahara, Katsuhiro Tamura, Chikage Iguchi, Michio Takamura, Susumu Sasaki, Kunihiro Yamasawa, Ming Dong
Publikováno v:
Oncology. 61:79-89
Objective: The biological activities of interleukin-17 (IL-17), a newly cloned cytokine, have not been fully elucidated. The present study was designed to assess the in vitro and in vivo effect of transfecting the IL-17 gene into tumor cells. Methods
Autor:
Chikage Iguchi, Tomoko Toga, Katsuhiro Tamura, Kunihiro Yamasawa, Ming Dong, Yoshinori Nio, Masayuki Itakura
Publikováno v:
Journal of Surgical Oncology. 76:188-196
Background and Objectives p53 tumor suppressor gene has a dual role as a trigger of apoptosis and as an initiator of DNA repair. The Bcl-2 can work to protect cells from apoptosis, which is induced by p53 gene. These facts suggest the significant rol
Autor:
Yoshinori Nio, Chikage Iguchi, Michio Takamura, Susumu Sasaki, Katsuhiro Tamura, Noriyuki Hirahara, Yoshimitsu Minari, Ming Dong, Ken Uegaki
Publikováno v:
Pancreas. 18:117-126
Summary p53 tumor-suppressor gene has a dual role as a trigger of apoptosis and as an initiator of DNA repair. The cyclin-dependent kinase inhibitor WAF/1-p21 is induced by wild-type p53 and has been implicated as a downstream mediator of the growth-
Autor:
Yoshinori, Nio, Chikage, Iguchi, Masayuki, Itakura, Takeshi, Nishi, Koji, Hashimoto, Hiroshi, Takeda, Michio, Takamura, Hiroshi, Omori, Yoshitoshi, Sato, Makoto, Koike, Shin-Ichiro, Endo
Publikováno v:
Anticancer research. 29(8)
Advanced or recurrent pancreatic cancer can sometimes cause obstruction or stenosis of the portal vein (PV), resulting in various symptoms of portal hypertension (PH), such as ascites, pancytopenia, hemorrhagic tendencies and liver dysfunction. We pl